Clinical Trial Detail

NCT ID NCT03844997
Title Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aziz Nazha
Indications

acute myeloid leukemia

Therapies

CPX-351 + Palbociclib

Age Groups: senior adult

No variant requirements are available.